Vicore Pharma Holding AB (publ) Total Assets

Latest as of December 2025: Skr1.22 Billion SEK ≈ $131.25 Million USD

Vicore Pharma Holding AB (publ) total assets. Based on the latest financial reports, Vicore Pharma Holding AB (publ) (VICO) holds total assets worth Skr1.22 Billion SEK (≈ $131.25 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Vicore Pharma Holding AB (publ) worth for the company's overall valuation and market capitalisation.

Total Assets of Vicore Pharma Holding AB (publ) (2012–2025)

Total assets of Vicore Pharma Holding AB (publ) from 2012 to 2025. This chart illustrates how Vicore Pharma Holding AB (publ)'s total assets have evolved over time, based on quarterly financial data. See current stock price of Vicore Pharma Holding AB (publ) for real-time trading data and today's change.

Vicore Pharma Holding AB (publ) - Asset Composition Analysis

Vicore Pharma Holding AB (publ) Total Assets Breakdown (December 2025)

Vicore Pharma Holding AB (publ) total assets breakdown as of December 2025. Vicore Pharma Holding AB (publ)'s total assets of Skr1.22 Billion consist of 100.0% current assets and 0.0% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr0.00	47.4%
Accounts Receivable	Skr13.80 Million	1.1%
Inventory	Skr0.00	0.0%
Property, Plant & Equipment	Skr0.00	0.0%
Intangible Assets	Skr0.00	0.0%
Goodwill	Skr0.00	0.0%

Asset Composition Trend (2012–2025)

This chart illustrates how Vicore Pharma Holding AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Vicore Pharma Holding AB (publ) (VICO) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Vicore Pharma Holding AB (publ)'s current assets represent 100.0% of total assets in 2025, an increase from 13.2% in 2012.
Cash Position: Cash and equivalents constituted 47.4% of total assets in 2025, up from 9.7% in 2012.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 41.0% in 2012.
Asset Diversification: The largest asset category is accounts receivable at 1.1% of total assets.

Vicore Pharma Holding AB (publ) Competitors by Total Assets

Key competitors of Vicore Pharma Holding AB (publ) based on total assets are shown below.

Company	Country	Total Assets
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	USA	$1.26 Billion
Verona Pharma plc F:I9SA	Germany	€572.87 Million
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	USA	$641.76 Million
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	China	CN¥37.46 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
Bavarian Nordic CO:BAVA	Denmark	Dkr14.95 Billion
Hebei Changshan Biochem Pharma SHE:300255	China	CN¥4.66 Billion

Vicore Pharma Holding AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	10.31	16.50	14.68
Quick Ratio	10.31	16.50	14.74
Cash Ratio	0.00	0.00	0.00
Working Capital	Skr1.10 Billion	Skr1.13 Billion	Skr556.03 Million

Vicore Pharma Holding AB (publ) - Advanced Valuation Insights

This section examines the relationship between Vicore Pharma Holding AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.51
Latest Market Cap to Assets Ratio	0.23
Asset Growth Rate (YoY)	1.4%
Total Assets	Skr1.22 Billion
Market Capitalization	$278.73 Million USD

Valuation Analysis

Below Book Valuation: The market values Vicore Pharma Holding AB (publ)'s assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Vicore Pharma Holding AB (publ)'s assets grew by 1.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Vicore Pharma Holding AB (publ) (2012–2025)

The table below shows the annual total assets of Vicore Pharma Holding AB (publ) from 2012 to 2025.

Year	Total Assets	Change
2025-12-31	Skr1.22 Billion ≈ $131.25 Million	+1.37%
2024-12-31	Skr1.20 Billion ≈ $129.47 Million	+141.67%
2023-12-31	Skr497.84 Million ≈ $53.58 Million	+47.29%
2022-12-31	Skr338.01 Million ≈ $36.37 Million	-25.08%
2021-12-31	Skr451.17 Million ≈ $48.55 Million	+10.98%
2020-12-31	Skr406.51 Million ≈ $43.75 Million	+19.17%
2019-12-31	Skr341.11 Million ≈ $36.71 Million	+13.10%
2018-12-31	Skr301.60 Million ≈ $32.46 Million	+152.33%
2017-12-31	Skr119.53 Million ≈ $12.86 Million	+46.39%
2016-12-31	Skr81.65 Million ≈ $8.79 Million	-8.49%
2015-12-31	Skr89.22 Million ≈ $9.60 Million	+50.29%
2014-12-31	Skr59.37 Million ≈ $6.39 Million	+16.45%
2013-12-31	Skr50.98 Million ≈ $5.49 Million	+132878.58%
2012-12-31	Skr38.34K ≈ $4.13K	--

About Vicore Pharma Holding AB (publ)

ST:VICO Sweden Biotechnology

Market Cap

$278.73 Million

Skr2.59 Billion SEK

Market Cap Rank

#14921 Global

#245 in Sweden

Share Price

Skr9.20

Change (1 day)

-0.43%

52-Week Range

Skr8.70 - Skr15.68

All Time High

Skr37.60